Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae : a case series and review of the literature
INTRODUCTION: The novel coronavirus SARS-CoV-2 has spread all over the world causing a global pandemic and representing a great medical challenge. Nowadays, there is limited knowledge on the rate of co-infections with other respiratory pathogens, with viral co-infection being the most representative agents. Co-infection with Mycoplasma pneumoniae has been described both in adults and pediatrics whereas only two cases of Chlamydia pneumoniae have been reported in a large US study so far.
METHODS: In the present report, we describe a series of seven patients where co-infection with C. pneumoniae (n = 5) or M. pneumoniae (n = 2) and SARS-CoV-2 was detected in a large teaching hospital in Rome.
RESULTS AND CONCLUSION: An extensive review of the updated literature regarding the co-infection between SARS-CoV-2 and these atypical pathogens is also performed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Infection - 48(2020), 6 vom: 02. Dez., Seite 871-877 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oliva, Alessandra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 08.12.2020 Date Revised 30.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s15010-020-01483-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313012768 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313012768 | ||
| 003 | DE-627 | ||
| 005 | 20240330232652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s15010-020-01483-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1356.xml |
| 035 | |a (DE-627)NLM313012768 | ||
| 035 | |a (NLM)32725598 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oliva, Alessandra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae |b a case series and review of the literature |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.12.2020 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: The novel coronavirus SARS-CoV-2 has spread all over the world causing a global pandemic and representing a great medical challenge. Nowadays, there is limited knowledge on the rate of co-infections with other respiratory pathogens, with viral co-infection being the most representative agents. Co-infection with Mycoplasma pneumoniae has been described both in adults and pediatrics whereas only two cases of Chlamydia pneumoniae have been reported in a large US study so far | ||
| 520 | |a METHODS: In the present report, we describe a series of seven patients where co-infection with C. pneumoniae (n = 5) or M. pneumoniae (n = 2) and SARS-CoV-2 was detected in a large teaching hospital in Rome | ||
| 520 | |a RESULTS AND CONCLUSION: An extensive review of the updated literature regarding the co-infection between SARS-CoV-2 and these atypical pathogens is also performed | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Chlamydia pneumoniae | |
| 650 | 4 | |a Co-infection | |
| 650 | 4 | |a Mycoplasma pneumoniae | |
| 650 | 4 | |a SARS-CoV-2 infection | |
| 700 | 1 | |a Siccardi, G |e verfasserin |4 aut | |
| 700 | 1 | |a Migliarini, A |e verfasserin |4 aut | |
| 700 | 1 | |a Cancelli, F |e verfasserin |4 aut | |
| 700 | 1 | |a Carnevalini, M |e verfasserin |4 aut | |
| 700 | 1 | |a D'Andria, M |e verfasserin |4 aut | |
| 700 | 1 | |a Attilia, I |e verfasserin |4 aut | |
| 700 | 1 | |a Danese, V C |e verfasserin |4 aut | |
| 700 | 1 | |a Cecchetti, V |e verfasserin |4 aut | |
| 700 | 1 | |a Romiti, R |e verfasserin |4 aut | |
| 700 | 1 | |a Ceccarelli, G |e verfasserin |4 aut | |
| 700 | 1 | |a Mastroianni, C M |e verfasserin |4 aut | |
| 700 | 1 | |a Palange, P |e verfasserin |4 aut | |
| 700 | 1 | |a Venditti, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection |d 1973 |g 48(2020), 6 vom: 02. Dez., Seite 871-877 |w (DE-627)NLM00001740X |x 1439-0973 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2020 |g number:6 |g day:02 |g month:12 |g pages:871-877 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s15010-020-01483-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2020 |e 6 |b 02 |c 12 |h 871-877 | ||